J
Jason Ellul
Researcher at Peter MacCallum Cancer Centre
Publications - 23
Citations - 2343
Jason Ellul is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Regulation of gene expression & Exome. The author has an hindex of 16, co-authored 22 publications receiving 1904 citations. Previous affiliations of Jason Ellul include University of Melbourne.
Papers
More filters
Journal ArticleDOI
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch,Ann-Marie Patch,Elizabeth L. Christie,Dariush Etemadmoghadam,Dariush Etemadmoghadam,Dale W. Garsed,Joshy George,Sian Fereday,Katia Nones,Katia Nones,Prue A. Cowin,Kathryn Alsop,Peter Bailey,Peter Bailey,Karin S. Kassahn,Karin S. Kassahn,Felicity Newell,Michael C.J. Quinn,Michael C.J. Quinn,Stephen H. Kazakoff,Stephen H. Kazakoff,Kelly Quek,Charlotte Wilhelm-Benartzi,Edward Curry,Huei San Leong,Anne Hamilton,Anne Hamilton,Anne Hamilton,Linda Mileshkin,George Au-Yeung,Catherine Kennedy,Jillian Hung,Yoke Eng Chiew,Paul R. Harnett,Michael Friedlander,Michael C. J. Quinn,Jan Pyman,Stephen Cordner,Patricia C. M. O’Brien,Jodie Leditschke,Greg Young,Kate Strachan,Paul Waring,Walid J Azar,Chris Mitchell,Nadia Traficante,Joy Hendley,Heather Thorne,Mark Shackleton,David Miller,Gisela Mir Arnau,Richard W. Tothill,Timothy P. Holloway,Timothy Semple,Ivon Harliwong,Craig Nourse,Ehsan Nourbakhsh,Suzanne Manning,Senel Idrisoglu,Timothy J. C. Bruxner,Angelika N. Christ,Barsha Poudel,Oliver Holmes,Oliver Holmes,Matthew J. Anderson,Conrad Leonard,Conrad Leonard,Andrew Lonie,Nathan E. Hall,Scott Wood,Scott Wood,Darrin Taylor,Qinying Xu,Qinying Xu,J. Lynn Fink,Nick Waddell,Ronny Drapkin,Euan A. Stronach,Hani Gabra,Robert S. Brown,A. Jewell,Shivashankar H. Nagaraj,Emma Markham,Peter Wilson,Jason Ellul,Orla McNally,Maria A. Doyle,Ravikiran Vedururu,Collin Stewart,Ernst Lengyel,John V. Pearson,John V. Pearson,Nicola Waddell,Nicola Waddell,Anna deFazio,Sean M. Grimmond,Sean M. Grimmond,David D.L. Bowtell,David D.L. Bowtell,David D.L. Bowtell +99 more
TL;DR: It is shown that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance.
Journal ArticleDOI
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.
Stephen Q. Wong,Jason Li,Angela Y-C Tan,Ravikiran Vedururu,Jia-Min B Pang,Jia-Min B Pang,Hongdo Do,Jason Ellul,Ken Doig,Anthony Bell,Grant A. McArthur,Grant A. McArthur,Stephen B. Fox,David Thomas,David Thomas,David Thomas,Andrew Fellowes,John P Parisot,John P Parisot,Alexander Dobrovic +19 more
TL;DR: These findings indicate that DNA damage following formalin fixation remains a major challenge in laboratories working with MPS, and methodologies that assess, minimise or remove formalin-induced DNA damaged templates as part of MPS protocols will aid in the interpretation of genomic results leading to better patient outcomes.
Journal ArticleDOI
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
Ella R. Thompson,Maria A. Doyle,Georgina L Ryland,Simone M Rowley,David Y.H. Choong,Richard W. Tothill,Heather Thorne,Daniel R. Barnes,Jason Li,Jason Ellul,Gayle K Philip,Yoland Antill,Paul A. James,Alison H. Trainer,Gillian Mitchell,Ian G. Campbell +15 more
TL;DR: The data demonstrate the utility of intra-family exome-sequencing approaches to uncover cancer predisposing genes, but highlight the major challenge of definitively validating candidates where the incidence of sporadic disease is high, germline mutations are not fully penetrant, and individual predisposition genes may only account for a tiny proportion of breast cancer families.
Journal ArticleDOI
c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation
Gretchen Poortinga,Meaghan Wall,Elaine Sanij,Kasia Siwicki,Jason Ellul,Daniel Brown,Timothy P. Holloway,Ross D. Hannan,Grant A. McArthur +8 more
TL;DR: In this paper, the authors demonstrate a robust reduction of loading onto rDNA that along with a depletion of the MYC target gene upstream binding factor (UBF) and a switch from epigenetically active to silent rDNA accompanies this MYC reduction.
Journal ArticleDOI
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Karen E. Sheppard,Karen E. Sheppard,Carleen Cullinane,Katherine M. Hannan,Katherine M. Hannan,Meaghan Wall,Joanna C. Chan,Frances Barber,Jung Hock Foo,Donald P. Cameron,Amelia Neilsen,Pui Ng,Jason Ellul,Margarete Kleinschmidt,Kathryn M Kinross,Kathryn M Kinross,David D.L. Bowtell,David D.L. Bowtell,James G. Christensen,Rodney J. Hicks,Rodney J. Hicks,Ricky W. Johnstone,Ricky W. Johnstone,Grant A. McArthur,Ross D. Hannan,Wayne A. Phillips,Wayne A. Phillips,Richard B. Pearson,Richard B. Pearson +28 more
TL;DR: These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.